关注
Thales Kronenberger
Thales Kronenberger
University Hospital of Tübingen - DZIF Tübingen Partner site
在 uni-tuebingen.de 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Advances with support vector machines for novel drug discovery
VG Maltarollo, T Kronenberger, GZ Espinoza, PR Oliveira, KM Honorio
Expert opinion on drug discovery 14 (1), 23-33, 2019
862019
Oxidative stress control by apicomplexan parasites
SS Bosch, T Kronenberger, KA Meissner, FM Zimbres, D Stegehake, ...
BioMed Research International 2015 (1), 351289, 2015
532015
Small-molecule thioesters as SARS-CoV-2 main protease inhibitors: enzyme inhibition, structure–activity relationships, antiviral activity, and X-ray structure determination
T Pillaiyar, P Flury, N Krüger, H Su, L Schäkel, E Barbosa Da Silva, ...
Journal of Medicinal Chemistry 65 (13), 9376-9395, 2022
442022
The application of machine learning techniques to innovative antibacterial discovery and development
MSM Serafim, T Kronenberger, PR Oliveira, A Poso, KM Honorio, ...
Expert Opinion on Drug Discovery 15 (10), 1165-1180, 2020
382020
ADME profiling in drug discovery and a new path paved on silica
A Krüger, V Gonçalves Maltarollo, C Wrenger, T Kronenberger
Drug discovery and development-new advances, 1-30, 2019
382019
HQSAR and random forest-based QSAR models for anti-T. vaginalis activities of nitroimidazoles derivatives
GC Verissimo, EFM Dutra, ALT Dias, P de Oliveira Fernandes, ...
Journal of Molecular Graphics and Modelling 90, 180-191, 2019
312019
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer
R Rudalska, J Harbig, MT Snaebjornsson, S Klotz, S Zwirner, L Taranets, ...
Nature cancer 2 (2), 201-217, 2021
292021
Structure-based design of selective salt-inducible kinase inhibitors
R Tesch, M Rak, M Raab, LM Berger, T Kronenberger, AC Joerger, ...
Journal of Medicinal Chemistry 64 (12), 8142-8160, 2021
282021
The inner rod of virulence‐associated type III secretion systems constitutes a needle adapter of one helical turn that is deeply integrated into the system's export apparatus
CE Torres‐Vargas, T Kronenberger, N Roos, T Dietsche, A Poso, ...
Molecular microbiology 112 (3), 918-931, 2019
282019
Vitamin B6‐Dependent Enzymes in the Human Malaria Parasite Plasmodium falciparum: A Druggable Target?
T Kronenberger, J Lindner, KA Meissner, FM Zimbres, MA Coronado, ...
BioMed Research International 2014 (1), 108516, 2014
282014
Molecular modeling applied to nucleic acid-based molecule development
A Krüger, FM Zimbres, T Kronenberger, C Wrenger
Biomolecules 8 (3), 83, 2018
272018
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
T Kronenberger, SA Laufer, T Pillaiyar
Drug Discovery Today, 103579, 2023
252023
Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease Mpro and Papain-like Protease PLpro of SARS-CoV-2
LH Santos, T Kronenberger, RG Almeida, EB Silva, REO Rocha, ...
Journal of Chemical Information and Modeling 62 (24), 6553-6573, 2022
242022
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): A study protocol
JB Borges, VF de Oliveira, GM Ferreira, B Los, TKAA Barbosa, ...
Research in social and administrative pharmacy 17 (7), 1347-1355, 2021
232021
Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses
T Kronenberger, LR Asse Jr, C Wrenger, GHG Trossini, KM Honorio, ...
Future medicinal chemistry 9 (2), 135-151, 2017
232017
Preclinical toxicity of innovative molecules: In vitro, in vivo and metabolism prediction
DR Tonholo, VG Maltarollo, T Kronenberger, IR Silva, PO Azevedo, ...
Chemico-Biological Interactions 315, 108896, 2020
222020
Advances and challenges in drug design of PPARδ ligands
VG Maltarollo, T Kronenberger, B Windshugel, C Wrenger, GHG Trossini, ...
Current Drug Targets 19 (2), 144-154, 2018
202018
Antibacterial activity of synthetic 1, 3‐bis (aryloxy) propan‐2‐amines against Gram‐positive bacteria
MSM Serafim, SN Lavorato, T Kronenberger, YV Sousa, GP Oliveira, ...
Microbiologyopen 8 (11), e814, 2019
192019
Targeting the Plasmodium falciparum plasmepsin V by ligand‐based virtual screening
KA Meissner, T Kronenberger, VG Maltarollo, GHG Trossini, C Wrenger
Chemical Biology & Drug Design 93 (3), 300-312, 2019
192019
Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles
O Burk, M Kuzikov, T Kronenberger, J Jeske, O Keminer, WE Thasler, ...
Archives of Toxicology 92, 1435-1451, 2018
182018
系统目前无法执行此操作,请稍后再试。
文章 1–20